This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Welch Allyn Holdings, Inc.
Welch Allyn Holdings, Inc., a prominent name in the medical device industry, is headquartered in the United States. Founded in 1915, the company has established itself as a leader in diagnostic and therapeutic equipment, primarily serving healthcare professionals across various settings. With a strong presence in North America and Europe, Welch Allyn is renowned for its innovative products, including vital signs monitors, otoscopes, and ophthalmoscopes, which are designed to enhance patient care and streamline clinical workflows. The company has achieved significant milestones, including advancements in digital diagnostics and connectivity solutions that set it apart in the market. Welch Allyn's commitment to quality and innovation has solidified its position as a trusted partner in healthcare, making it a go-to choice for medical practitioners seeking reliable and effective diagnostic tools.
DitchCarbon Score
How does Welch Allyn Holdings, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Welch Allyn Holdings, Inc.'s score of 30 is higher than 55% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Welch Allyn Holdings, Inc., headquartered in the US, currently does not have specific carbon emissions data available for recent years. The company is a current subsidiary of Hill-Rom Holdings, Inc., which may influence its climate commitments and performance metrics. Emissions data may also be inherited from Baxter International Inc., as part of a cascading relationship. Despite the absence of specific emissions figures, Welch Allyn is part of a broader corporate family that is likely engaged in various climate initiatives. However, there are no documented reduction targets or climate pledges directly associated with Welch Allyn at this time. The lack of specific data highlights the need for transparency and commitment to sustainability within the medical technology sector. As the industry increasingly focuses on reducing carbon footprints, it is essential for Welch Allyn to establish clear climate commitments and reduction targets to align with global sustainability goals.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2024 | |
|---|---|---|---|
| Scope 1 | - | 00,000,000 | 0,000,000,000 |
| Scope 2 | 43,469,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | 0,000,000 | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Welch Allyn Holdings, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
